AK

Ashok Kumar

Director Director DIN 03331758
DIN 03331758 First appointment Feb 2011 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Ashok Kumar

Data last updated:

Ashok Kumar was a Director at Manas Healthcare Private Limited (2011–2019) and Additional Director at Standard Medicines Private Limited (2011). The companies operate in Healthcare and Trading.

DIN 03331758
Primary Designation Director
Industry Healthcare
First Appointment 01 Feb 2011

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Manas Healthcare Private Limited U24239MH2011PTC214971
Director18 Mar 20112011Active
Standard Medicines Private Limited U24232DL2008PTC183301
Additional Director01 Feb 20112008Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Manas Healthcare Private Limited
Standard Medicines Private Limited
Premium access

Shareholding and investment profile for Ashok Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashok Kumar

Ashok Kumar was first appointed on 01 Feb 2011 as Additional Director at Standard Medicines Private Limited.

Ashok Kumar held 2 earlier board appointments: Manas Healthcare Private Limited (Director, 18 Mar 2011 to 26 Mar 2019); Standard Medicines Private Limited (Additional Director, 01 Feb 2011 to 30 Sep 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available